Vystar Corp operates in three distinct yet niche areas: Vytex natural rubber latex, RxAir UV-based air purifiers, and Fluid Energy Conversion green energy technologies. Despite proprietary technology and some FDA clearances, the company has a limited operating history with volatile revenue and continuing net losses, burdened by thin liquidity and heavy operational costs. Vystar’s growth hinges on expanding sales of its products and capital raises, while its small scale and competitive markets pose ongoing challenges. The firm maintains substantial accumulated deficits and negative equity, with no dividend payments anticipated in the foreseeable future.